###begin article-title 0
alpha-Actinin-4-Mediated FSGS: An Inherited Kidney Disease Caused by an Aggregated and Rapidly Degraded Cytoskeletal Protein
###end article-title 0
###begin article-title 1
A Protein's Role in Progressive Renal Disease
###end article-title 1
###begin p 2
###xml 248 253 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 856 861 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 1211 1216 1191 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 1353 1358 1333 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 172 175 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 432 437 <span type="species:ncbi:10090">mouse</span>
###xml 831 836 <span type="species:ncbi:10090">mouse</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 1155 1160 <span type="species:ncbi:9606">human</span>
###xml 1180 1184 <span type="species:ncbi:10090">mice</span>
###xml 1274 1280 <span type="species:ncbi:9606">humans</span>
###xml 1384 1388 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
###xml 1464 1470 <span type="species:ncbi:9606">humans</span>
Focal segmental glomerulosclerosis (FSGS) is a common pattern of renal injury, seen as both a primary disorder and as a consequence of underlying insults such as diabetes, HIV infection, and hypertension. Point mutations in thealpha-actinin-4 gene ACTN4 cause an autosomal dominant form of human FSGS. We characterized the biological effect of these mutations by biochemical assays, cell-based studies, and the development of a new mouse model. We found that a fraction of the mutant protein forms large aggregates with a high sedimentation coefficient. Localization of mutant alpha-actinin-4 in transfected and injected cells, as well as in situ glomeruli, showed aggregates of the mutant protein. Video microscopy showed the mutant alpha-actinin-4 to be markedly less dynamic than the wild-type protein. We developed a "knockin" mouse model by replacing Actn4 with a copy of the gene bearing an FSGS-associated point mutation. We used cells from these mice to show increased degradation of mutant alpha-actinin-4, mediated, at least in part, by the ubiquitin-proteasome pathway. We correlate these findings with studies of alpha-actinin-4 expression in human samples. "Knockin" mice with a disease-associated Actn4 mutation develop a phenotype similar to that observed in humans. Comparison of the phenotype in wild-type, heterozygous, and homozygous Actn4 "knockin" and "knockout" mice, together with our in vitro data, suggests that the phenotypes in mice and humans involve both gain-of-function and loss-of-function mechanisms.
###end p 2
###begin p 3
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 48 53 <span type="species:ncbi:9606">human</span>
Transgenic experiments in mice suggest that the human kidney disorder, focal segmental glomerulosclerosis (FSGS), is a result of both gain- and loss-of-function mechanisms
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 86 104 86 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 350 372 350 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Ichikawa1">Ichikawa and Fogo 1996</xref>
###xml 374 395 374 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Somlo1">Somlo and Mundel 2000</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
###xml 307 310 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In humans, ACTN4 mutations cause a form of focal segmental glomerulosclerosis (FSGS) (Kaplan et al. 2000). This lesion, which describes a pattern of injury characterized by regions of sclerosis in some renal glomeruli, is a common finding in kidney disease from a wide range of primary disorders, including HIV infection, diabetes, and hypertension (Ichikawa and Fogo 1996; Somlo and Mundel 2000).
###end p 5
###begin p 6
###xml 316 333 304 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Honda1">Honda et al. 1998</xref>
###xml 335 356 323 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Takada1">Takada and Beggs 2002</xref>
###xml 569 587 537 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 510 515 <span type="species:ncbi:9606">human</span>
The four alpha-actinin genes encode highly homologous proteins that normally form approximately 100 kDa head-to-tail homodimers. While the best-defined function of alpha-actinin-4 is to cross-link and bundle actin filaments, alpha-actinins have been found to interact with a large and diverse set of other proteins (Honda et al. 1998; Takada and Beggs 2002). alpha-Actinin-2 and alpha-actinin-3 are located predominantly in the sarcomere, while alpha-actinin-1 and alpha-actinin-4 are widely expressed. In the human kidney, only alpha-actinin-4 expression is detected (Kaplan et al. 2000).
###end p 6
###begin p 7
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 224 239 224 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 427 432 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 490 509 490 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Michaud1">Michaud et al. 2003</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 242 257 <span type="species:ncbi:10090">Transgenic mice</span>
Human ACTN4-associated FSGS is inherited in an autosomal dominant pattern. By contrast, mice homozoygous for Actn4 null alleles have glomerular disease, while heterozygous Actn4 null mice have no readily apparent phenotype (Kos et al. 2003). Transgenic mice harboring a mutant Actn4 targeted to the glomerular podocyte have an FSGS-like lesion, although it is not clear whether this is due to the dominant effect of the mutant Actn4 per se or to dysregulated Actn4 expression in this cell (Michaud et al. 2003).
###end p 7
###begin p 8
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 110 128 106 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 190 209 186 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Michaud1">Michaud et al. 2003</xref>
###xml 571 576 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 930 935 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 330 335 <span type="species:ncbi:9606">human</span>
###xml 751 756 <span type="species:ncbi:10090">mouse</span>
We previously showed that FSGS-associated ACTN4 mutations increase the binding of alpha-actinin-4 to F-actin (Kaplan et al. 2000). This was confirmed independently by different methodology (Michaud et al. 2003). However, the relationship between altered actin binding and disease is unclear. Of particular interest is whether the human disease is due to a gain-of-function effect of mutations on protein function or due to a partial loss of normal function. We therefore performed a series of experiments to help us understand the biological consequences of mutations in ACTN4. We demonstrate here that mutant alpha-actinins exhibit altered structural characteristics, localize abnormally, and have significantly diminished half-life. By developing a mouse model harboring a disease-associated point mutation, we confirm the pathologic effect of this mutation on glomerular function. Our results suggest that the major effects of Actn4 mutations are protein misfolding and accelerated degradation, leading to loss of normal alpha-actinin-4 function, alpha-actinin-4 aggregation, and progressive kidney disease.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Mutant alpha-Actinin-4 Conformation
###end title 10
###begin p 11
###xml 36 52 36 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Chan1">Chan et al. 1998</xref>
###xml 1026 1053 990 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Feramisco1">Feramisco and Burridge 1980</xref>
###xml 1322 1330 1282 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g001">Figure 1</xref>
###xml 1810 1818 1754 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g001">Figure 1</xref>
In overlay assays (performed as per Chan et al. 1998; data not shown), mutant alpha-actinin-4 is able to bind both mutant and wild-type alpha-actinin-4. Since mutant alpha-actinin-4 polypeptides are able to interact, we used sucrose gradient assays to examine whether the mutant alpha-actinin-4 dimerizes normally. We produced radiolabeled in vitro translated wild-type and mutant alpha-actinin-4 (K228E, T232I, R235P) and subjected these proteins to centrifugation in 5%-20% sucrose gradients. We found that all of the wild-type alpha-actinin-4 eluted as a single peak, as expected. By contrast, approximately 80% mutant alpha-actinin-4 eluted at the same peak as in wild-type, while about 20% of the mutant protein eluted much more quickly and peaked in the first fraction. We then used a 10%-40% sucrose gradient in an attempt to better characterize this small peak. Again, in multiple experiments, about 20% of the mutant alpha-actinins eluted in the first fractions. alpha-Actinin has a sedimentation coefficient of 6.4 (Feramisco and Burridge 1980), and both wild-type and the majority (approximately 80%) of mutant actinins migrated in this position. However, a significant fraction of mutant alpha-actinin-4 had a sedimentation coefficient equal to or greater than 11.3, the sedimentation coefficient of catalase (Figure 1). This extremely high sedimentation rate suggests either the presence of large alpha-actinin-4 multimers or the existence of large (and perhaps insoluble) aggregates. When these experiments were performed in the presence of a large excess of cold alpha-actinin, this rapidly sedimenting fraction of mutant alpha-actinin was unchanged, showing that the abnormally conformed mutant alpha-actinin-4 could not be shifted back into normally sedimenting mutant/wild-type heterodimers (Figure 1).
###end p 11
###begin title 12
alpha-Actinin-4 Behavior in Cells
###end title 12
###begin p 13
###xml 979 987 963 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g002">Figure 2</xref>
###xml 999 1011 983 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="sv001">Videos S1&#8211;S3</xref>
###xml 1108 1113 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 1113 1122 1097 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228/K228</sup>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
We performed both transfection and nuclear injection studies in a conditionally immortalized podocyte cell line to look at the effect of disease-associated mutations on alpha-actinin-4 localization. Irrespective of the method used to express the mutant alpha-actinins in cells, we found altered localization of the mutants. Consistent with the altered sedimentation observed in vitro, mutant alpha-actinin-4 formed localized aggregates when expressed in cells. We used video microscopy to view the fate of the green fluorescent protein (GFP)-alpha-actinin-4 after nuclear injection of the cDNA. Similar results were observed in three independent sets of experiments. In each experiment, 15-35 cells were microinjected in the nucleus with plasmid DNA; of these, five to ten cells showed signal at 4-6 h after injection. Consistently, the mutants behaved abnormally, were unevenly distributed in the cell cytoplasm, and were much less dynamic compared with the wild-type proteins (Figure 2A; see also Videos S1-S3). These findings were consistent with the indirect immunofluorescence (IF) studies performed in Actn4K228/K228 mice (see below).
###end p 13
###begin p 14
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 80 87 80 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 98 109 98 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 194 202 186 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g002">Figure 2</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
We transfected conditionally immortalized podocytes derived from Actn4+/+, Actn4K228E/+, and Actn4K228E/K228E mice with either wild-type GFP-alpha-actinin-4 or K228E mutant GFP-alpha-actinin-4 (Figure 2B). The wild-type GFP-alpha-actinin-4 showed diffuse cytoplasmic localization in podocytes of all three genotypes. By contrast, mutant alpha-actinin-4 showed a similar aggregated appearance in all three cell types. This suggests the absence of a strong dominant effect of the mutant protein on the wild-type, as the endogenous K228E actinin does not alter the localization of the wild-type GFP-tagged protein.
###end p 14
###begin p 15
###xml 142 147 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 166 181 162 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 214 222 210 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g003">Figure 3</xref>
###xml 257 260 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 317 321 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 410 415 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 415 422 411 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 478 483 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 483 494 479 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 617 632 613 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 681 686 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 734 739 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 757 765 753 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g003">Figure 3</xref>
###xml 1128 1133 1120 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 1133 1144 1125 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 1195 1200 1187 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 1200 1207 1192 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 1223 1231 1215 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g003">Figure 3</xref>
###xml 1289 1294 1281 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 1435 1443 1423 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g003">Figure 3</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 261 276 <span type="species:ncbi:10090">transgenic mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1254 1259 <span type="species:ncbi:9606">human</span>
We developed alpha-actinin-4 "knockin" mice using the methods of homologous recombination in embryonic stem cells. Previously we developed an Actn4 "knockout" mouse (Kos et al. 2003). As indicated schematically in Figure 3A, mating these mice with germline Cre transgenic mice produced offspring in which an intronic loxP-flanked neomycin resistance cassette had been excised. We bred these heterozygous mice (Actn4K228E/+) to generate litters with wild-type, heterozygous, and Actn4K228E/K228E mice. We genotyped mice by testing for the presence or absence of an engineered silent EarI site as described previously (Kos et al. 2003). The homozygous K228E mice, in contrast to the Actn4-deficient model, demonstrated normal levels of Actn4 mRNA expression (Figure 3B). RT-PCR and sequencing of the transcript confirmed that the K228E allele was in fact expressed in the homozoygous mice. However, in multiple tissues tested (kidney, lung, leukocytes, brain), as well as in fibroblasts derived from these mice, alpha-actinin-4 protein expression was markedly reduced, with an approximately 90% reduction in protein expression in Actn4K228E/K228E homozygotes and an approximately 50% reduction in Actn4K228E/+ heterozygotes (Figure 3D). Lymphocytes from a human subject heterozygous for one ACTN4 K2228E mutation similarly had an approximately 50% reduction in the amount of alpha-actinin-4 compared with related and unrelated controls (Figure 3E).
###end p 15
###begin title 16
alpha-Actinin-4 Degradation
###end title 16
###begin p 17
###xml 117 122 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 179 187 175 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g003">Figure 3</xref>
###xml 302 307 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 307 318 299 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 332 337 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 337 344 329 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 390 392 382 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 531 533 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 730 738 706 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g004">Figure 4</xref>
###xml 860 868 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g004">Figure 4</xref>
###xml 1097 1099 1061 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1370 1378 1330 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g004">Figure 4</xref>
###xml 1384 1385 1344 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g004">4</xref>
###xml 1771 1779 1715 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g004">Figure 4</xref>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
We observed decreased mutant alpha-actinin expression in an immortalized knockin mouse fibroblast homozygous for the Actn4 K228E mutation, compared with the wild-type fibroblast (Figure 3D). To help determine the fate of the mutant alpha-actinin, we performed pulse and pulse-chase studies. We labeled Actn4K228E/K228E fibroblasts, Actn4K228E/+ fibroblasts, and wild-type fibroblasts with [35S]methionine for different timepoints (pulse) following incubation in methionine-deficient medium. In order to trace the newly synthesized 35S-labeled alpha-actinins, we used an alpha-actinin-4-specific antibody to immunoprecipitate alpha-actinin-4 from the cell lysates. (We detected no alpha-actinin-4 in the cell pellets.) As shown in Figure 4A, we found that at any timepoint, there was less mutant than wild-type alpha-actinin-4 synthesized. However, as shown in Figure 4B, the rates of increase in labeled alpha-actinin-4 were similar, suggesting that the low expression level of mutant alpha-actinin-4 is not due to a defect in synthesis. We then labeled the mutant and wild-type fibroblasts with [35S]methionine for 3 hours (pulse), following incubation in methionine-deficient media, and then incubated the cells in media containing excess cold methionine (chase) for different timepoints to follow the degradation of the newly synthesized alpha-actinin-4. As shown in Figure 4C and 4D, mutant alpha-actinin-4 degraded at a much faster rate than did the wild-type protein. The estimated half-life of mutant alpha-actinin-4 is about 15 h, while the half-life of the wild-type alpha-actinin-4 is much greater than 30 h. Three replicate experiments gave the same results. The rapid degradation of the K228E mutant alpha-actinin-4 is reversed by treatment with lactacystin (Figure 4E), indicating that this mutant form of alpha-actinin-4 is degraded through the ubiquitin-proteasome pathway.
###end p 17
###begin title 18
In Vivo Phenotype
###end title 18
###begin p 19
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 63 73 63 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228/K228E</sup>
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 96 102 96 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228/+</sup>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 138 148 138 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228/K228E</sup>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 310 320 310 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228/K228E</sup>
###xml 472 480 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g005">Figure 5</xref>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 569 576 569 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 915 920 915 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 932 947 932 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 953 958 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 958 968 958 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228/K228E</sup>
###xml 1080 1088 1080 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g005">Figure 5</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">Mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
We performed standard histologic analyses of kidneys from Actn4K228/K228E mice, as well as Actn4K228/+ and wild-type littermates. In Actn4K228/K228E mice as old as 13 mo, we saw no abnormalities by light microscopy with periodic acid-Schiff (PAS) and hematoxylin-and-eosin (H & E) staining. All of the 11 Actn4K228/K228E kidneys examined by electron microscopy had abnormalities in podocyte structure. Typically, these consisted of focal areas of foot process effacement (Figure 5A). By contrast, we found mild abnormalities in one of 13 wild-type and one of nine Actn4K228E/+ littermates. Mice were typically genotyped at or shortly before the time of weaning (at approximately 3 wk of age). Only 10% (23 of 231) of the offspring of crosses between heterozygous mice were homozygous for the K228E change, suggesting increased peri- or neonatal lethality in the homozygous mice, similar to what we have observed in Actn4 null mice (Kos et al. 2003). In Actn4K228/K228E mice, we frequently observed the appearance of abnormal electron-dense structures in the podocyte cell bodies (Figure 5D).
###end p 19
###begin p 20
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8211;</sup>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 162 169 162 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 229 232 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 242 253 242 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 457 460 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8211;</sup>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 481 488 481 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 545 548 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 558 569 558 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 633 641 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g006">Figure 6</xref>
###xml 784 792 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g006">Figure 6</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 834 839 <span type="species:ncbi:10090">mouse</span>
We measured urine protein excretion in mice of five different genotypes: wild-type (Actn4+/+), heterozyogtes for either a null or K228E allele (Actn4+/- and Actn4K228E/+), and homozoygotes for either a null or K228E allele (Actn4-/- and Actn4K228E/K228E). Results were quite variable within each genotypic group of mice (likely reflecting differences in age and genetic background). However, the overall pattern of protein excretion was similar in the Actn4+/+, Actn4+/-, and Actn4K228E/+ mice, while both groups of homozygous mutant mice (Actn4-/- and Actn4K228E/K228E) had significantly greater-and similar-degrees of proteinuria (Figure 6B). We did not see significant differences in serum creatinine levels or blood urea nitrogen levels (BUN) between mice of the three genotypes (Figure 6A), nor did we identify any single mutant mouse with significant BUN or creatinine elevations.
###end p 20
###begin p 21
###xml 138 146 134 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g006">Figure 6</xref>
###xml 210 215 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 215 226 207 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 423 428 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 428 435 420 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 490 495 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 495 506 487 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
To determine whether the K228E point mutation altered alpha-actinin-4 localization in vivo, we performed indirect IF studies. As shown in Figure 6A, alpha-actinin-4 appears to be mislocalized and aggregated in Actn4K228E/K228E kidneys. By contrast, we see no difference in the expression of slit-diaphragm proteins ZO-1 and nephrin. The merged ZO-1/Actn4 images show overlapping patterns of expression in the wild-type and Actn4K228E/+ mice, but clearly distinct expression patterns in the Actn4K228E/K228E mice.
###end p 21
###begin p 22
###xml 52 57 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 57 64 53 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 87 95 83 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g006">Figure 6</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
We examined alpha-actinin-4 localization in a human ACTN4K228E/+ kidney biopsy sample (Figure 6B). Although we are cautious in our interpretation, given the availability of only one biopsy sample, there appears to be a more punctate appearance to the alpha-actinin-4 distribution, consistent with the existence of some alpha-actinin-4 aggregates in human heterozygotes.
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 95 100 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 143 161 139 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 264 279 256 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
We have previously shown that dominantly inherited point mutations in the alpha-actinin-4 gene ACTN4 cause a form of human glomerular disease (Kaplan et al. 2000). We have also shown that mice lacking alpha-actinin-4 expression develop a severe glomerular lesion (Kos et al. 2003). Here we have further explored the biochemical and cell biologic alterations caused by disease-associated alpha-actinin-4 mutations.
###end p 24
###begin p 25
###xml 589 608 585 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kestila1">Kestila et al. 1998</xref>
###xml 610 627 606 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Boute1">Boute et al. 2000</xref>
###xml 753 773 749 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Donoviel1">Donoviel et al. 2001</xref>
###xml 960 965 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 630 634 <span type="species:ncbi:10090">Mice</span>
Human alpha-actinin-4-associated FSGS is characterized by a dominant pattern of inheritance. Affected individuals typically develop disease in adulthood. Some individuals develop progressive renal failure, others develop moderate proteinuria, while a few show no evidence of kidney dysfunction well into adulthood. This contrasts with other recently elucidated inherited disorders of the podocyte caused by mutations in the slit-diaphragm proteins nephrin and podocin, where disease typically presents in the neonatal period or in childhood and follows a recessive pattern of inheritance (Kestila et al. 1998; Boute et al. 2000). Mice lacking slit-diaphragm proteins CD2AP and Neph-1 similarly present with very early-onset nephrosis (Shih et al. 1998; Donoviel et al. 2001). Furthermore, in contrast to the typically diffuse podocyte foot process effacement observed in kidney biopsies from individuals with these recessive forms of disease, individuals with ACTN4-associated FSGS have focal podocyte abnormalities, nonnephrotic levels of proteinuria, and slowly progressive adult-onset disease leading to significant (and often end-stage) renal failure in adulthood.
###end p 25
###begin p 26
###xml 799 811 787 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Horwich1">Horwich 2002</xref>
###xml 525 530 <span type="species:ncbi:9606">human</span>
###xml 536 541 <span type="species:ncbi:10090">mouse</span>
These phenotypic differences themselves suggest a different mechanism of disease from what is observed with slit-diaphragm protein defects. Our earlier experiments suggested that mutant alpha-actinin-4 binds actin filaments more strongly than wild-type alpha-actinin-4 in vitro. However, this may reflect a propensity toward oligomerization rather than increased F-actin binding per se. The finding that the mutant alpha-actinin-4 forms aggregates with greatly decreased half-life suggests two possible models to explain the human (and mouse) disease. One model would explain the development of podocyte damage as a direct effect of protein aggregation and the toxic effects of such aggregation, as is observed in several degenerative neurologic conditions such as Alzheimer and Parkinson diseases (Horwich 2002). The second model explains the disease as a loss-of-function disease, reflecting the increased rate of mutant alpha-actinin-4 degradation.
###end p 26
###begin p 27
###xml 558 581 554 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Bucciantini1">Bucciantini et al. 2002</xref>
###xml 583 593 579 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Bates1">Bates 2003</xref>
###xml 844 861 836 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-White1">White et al. 1997</xref>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
We do not regard these models as mutually exclusive. In fact, we believe it likely that the development of disease may involve both of these mechanisms. It is interesting to note that alpha-actinin-4-mediated kidney disease bears some similarities to the adult-onset neurodegenerative condition Huntington disease. In Huntington disease, dominant mutations that lead to expanded polyglutamine tracts cause neurodegeneration. The mutant huntingtin protein is misfolded and forms aggregates that are thought to have dominant, toxic effects on neuron function (Bucciantini et al. 2002; Bates 2003). These proteins also play critical and nonredundant roles in the relevant organs: analogous to what we have observed in alpha-actinin-4-deficient mice, mice with reduced huntingtin expression show abnormal brain development and perinatal lethality (White et al. 1997).
###end p 27
###begin p 28
###xml 481 499 473 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 1048 1053 1040 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 1191 1206 1179 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 15 21 <span type="species:ncbi:9606">humans</span>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 117 123 <span type="species:ncbi:9606">humans</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 346 352 <span type="species:ncbi:9606">humans</span>
###xml 410 416 <span type="species:ncbi:9606">humans</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 529 535 <span type="species:ncbi:10090">murine</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
###xml 919 925 <span type="species:ncbi:9606">humans</span>
###xml 1036 1042 <span type="species:ncbi:9606">humans</span>
###xml 1132 1136 <span type="species:ncbi:10090">mice</span>
###xml 1145 1151 <span type="species:ncbi:9606">humans</span>
###xml 1299 1304 <span type="species:ncbi:10090">mouse</span>
In contrast to humans, mice heterozygous for alpha-actinin-4 mutations do not have overt disease. We suspect that in humans, over a timespan of several decades, the combination of decreased alpha-actinin-4 expression and the formation of aggregates ultimately proves toxic. We suggest that the relatively short life of mice compared with that of humans may be the major explanation of this difference. Not all humans carrying disease-associated mutations develop clinical disease (Kaplan et al. 2000). Disease, in both human and murine heterozygotes, likely requires a "second hit," either in the strict genetic sense of a second mutation in the relevant cell type or a "physiologic hit," such as elevated blood pressure, renal toxin exposure, or vascular disease, to name three examples. We suspect that renal stresses will uncover deleterious renal phenotypes in heterozygous mice, similar to the disease observed in humans. With aging and gradual accumulation of aggregates in the terminally differentiated podocyte, we believe that humans with ACTN4 mutations become increasingly susceptible to minor insults. We note also that mice, unlike humans, express alpha-actinin-1 in podocytes (Kos et al. 2003). This may help stabilize mutant alpha-actinin-4 or may produce more redundancy, giving the mouse glomerulus greater protection to perturbations in this pathway.
###end p 28
###begin p 29
###xml 26 34 26 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g007">Figure 7</xref>
###xml 368 373 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 385 403 381 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 429 434 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 519 524 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 214 220 <span type="species:ncbi:9606">humans</span>
###xml 332 338 <span type="species:ncbi:9606">humans</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
We note that, as shown in Figure 7, the appearance of alpha-actinin-4 is more punctate in the kidney from a K228E heterozygous individual than a control, consistent with the existence of aggregates in heterozygous humans. This effect, however, is subtle, and is consistent with the lack of any detectable renal phenotype in several humans who carry disease-associated ACTN4 mutations (Kaplan et al. 2000). Although the number of ACTN4 mutations we have found is small, we have not detected any human disease-associated ACTN4 mutations to date that lead to premature termination, suggesting that simple haploinsufficiency may not by itself cause disease (our unpublished data).
###end p 29
###begin p 30
###xml 16 24 16 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020167-g005">Figure 5</xref>
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 270 277 270 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 376 387 376 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 781 786 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 786 797 770 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 905 911 <span type="species:ncbi:9606">humans</span>
As indicated in Figure 5 and in the text, heterozygous K228E Actn4 knockin mice have no clear phenotype either by histologic analysis at the light and electron microscopic levels or by analysis of urine protein and serum creatinine. Even at more advanced ages, the Actn4K228E/+ mice appear normal. By contrast, we observe clear glomerular phenotypes in both Actn4-/- and Actn4K228E/K228E mice. Our genetic observations are consistent with our biochemical observations. Specifically, we believe that alpha-actinin-4 mutations lead to a reduction in normal alpha-actinin-4 activity and to protein aggregation and that glomerular phenotypes reflect both loss of normal alpha-actinin-4 function and toxic effects of aggregated alpha-actinin-4. While the disease observed in homozygous Actn4K228E/K228E mice may primarily reflect loss of function resulting from rapid alpha-actinin-4 degradation, heterozygous humans may show slow development of podocyte damage from the effects of alpha-actinin-4 aggregation.
###end p 30
###begin p 31
###xml 334 353 326 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Shirato1">Shirato et al. 1996</xref>
###xml 355 373 347 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Smoyer1">Smoyer et al. 1997</xref>
Is alteration of alpha-actinin-4 expression or conformation a cause or a mediator of secondary forms of kidney disease? These seem plausible hypotheses given the data presented here, together with results from other investigators showing alterations in alpha-actinin-4 levels in association with proteinuria in certain animal models (Shirato et al. 1996; Smoyer et al. 1997). This suggests that physiologic processes that alter the expression, conformation, or both of this (and other) cytoskeletal proteins, either at the protein or the transcript level, might be amenable to interventions that restore normal patterns of protein expression.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33

###end title 33
###begin title 34
###xml 21 21 21 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
Cell and cell culture
###end title 34
###begin p 35
###xml 165 183 165 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Mundel1">Mundel et al. 1997</xref>
###xml 399 400 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 613 631 589 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Mundel1">Mundel et al. 1997</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 318 322 <span type="species:ncbi:9913">calf</span>
###xml 708 713 <span type="species:ncbi:10090">mouse</span>
Mouse podocytes were kindly provided by Dr. Peter Mundel (Albert Einstein College of Medicine, Bronx, New York, United States) and cultured as described previously (Mundel et al. 1997). In brief, undifferentiated podocytes were cultured in RPMI-1640 (Cellgro, CellGenix, Freiburg, Germany) medium containing 10% fetal calf serum (FCS) and 20 U/ml gamma-interferon (gamma-IFN) at 33degreesC and 5% CO2. Differentiated podocytes were cultured in the medium containing no gamma-IFN at 37degreesC. Additional conditionally immortalized podocytes from "knockin" litters were generated exactly as described previously (Mundel et al. 1997). Fibroblasts were derived from lungs dissected from newly sacrificed adult mouse littermates of different genotypes. Cells were propagated in culture and immortalized by transfection with an SV-40 large T-antigen expression plasmid using Fugene 6 transfection reagent (Roche, Basel, Switzerland).
###end p 35
###begin title 36
Protein extraction
###end title 36
###begin p 37
Fibroblasts were allowed to grow to confluence, then scraped off the tissue culture plate in the presence of cold phosphate-buffered saline (PBS) and spun at 3,000 rpm at 4degreesC for 10 min. Lymphocytes were isolated from whole blood with Histopaque-1077 solution (Sigma, St. Louis, Missouri, United States) following the manufacturer's instructions. The pellets were resuspended in ice-cold lysis buffer (150 mM NaCl, 50 mM Tris [pH 8.0], 1% Triton X-100, 1 mM Na-orthovanadate, 4 muM microcystin, and protease inhibitor). We collected the supernatant and estimated the protein concentration using either the Bradford method or equalizing the protein concentration in different lysates by Western blot using beta-actin as a standard.
###end p 37
###begin title 38
Transient transfection and Immunocytochemistry
###end title 38
###begin p 39
###xml 218 236 218 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 626 632 <span type="species:ncbi:9986">rabbit</span>
We mutated a wild-type pBluescript-GFP-ACTN4 clone using a QuickChange kit (Stratagene, La Jolla, California, United States) to create clones harboring each of three disease-associated mutations (K228E, T232I, S235P) (Kaplan et al. 2000). These mutant and wild-type alpha-actinin-4 clones were transfected into podocytes using Fugene 6 (Roche). Cells 60 h after transfection were fixed in 2% paraformaldehyde and 4% sucrose in PBS for 5 min and then permeabilized in 0.3% Triton for 5 min. Fixed cells were blocked with 2% FCS, 2% BSA, 0.2% fish gelatin in PBS for 60 min and incubated with anti-alpha-actinin-4 antibody, and rabbit antigen-antibody complexes were visualized with fluorochrome-conjugated secondary antibodies.
###end p 39
###begin title 40
Sucrose gradient studies
###end title 40
###begin p 41
Sucrose gradients of 5%-20% and 10%-40% were made using a buffer containing 0.02 M Tris-HCl (pH 7.5), 0.15M NaCl, 0.1 mM EDTA, and 0.2 mM of DTT and were internally calibrated with BSA, carbonic anhydrase, and catalase. In vitro translated and radiolabeled wild-type and mutant alpha-actinin-4 (K228E, T232I, S235P) were loaded onto the gradient, centrifuged at 40,000 rpm for 15 h at 4degreesC, and eluted into 0.2 ml fractions. Eluates were analyzed by SDS-PAGE and autoradiography.
###end p 41
###begin title 42
###xml 19 19 19 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
Pulse-chase studies
###end title 42
###begin p 43
###xml 231 233 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Immortalized mouse fibroblasts were incubated in methionine-free MEM medium containing 10% FCS (dialyzed overnight using 12K-14K SPECTRA/POR porous membrane in normal saline at 4degreesC) and 25 mM HEPES for 20 min at 37degreesC. [35S]Methionine was added to a final concentration of 0.1 mCi to pulse the cells. Cells were pulse labeled for 0, 15, 30, 60, 120, 180, and 240 min. To study the degradation of alpha-actinin-4, cells were pulsed for 3 h and then chased for 0, 3, 6, 12, 20, 24, and 30 h with excess cold methionine. We used anti-alpha-actinin-4 antibody recognizing the N-terminus to precipitate alpha-actinin-4 from the cell lysates. Protein A-sepharose beads (Pierce Biotechnology, Rockford, Illinois, United States) were preincubated with the anti-alpha-actinin-4 antibody for 2 h at 4degreesC and then incubated with the lysates overnight at 4degreesC. The beads were washed with lysis buffer and resuspended in SDS-PAGE loading buffer. Samples were resolved on a 10% polyacrylamide gel and visualized by exposure to radiographic film. For lactacystin treatment, cells were first pulsed for 3 h as above, followed by addition of 2.5 muM lactacystin dissolved in DMSO (A. G. Scientific, San Diego, California, United States) or 0.125% DMSO alone with cold methionine.
###end p 43
###begin title 44
Nuclear DNA injection and imaging
###end title 44
###begin p 45
For injection and imaging, cells were cultured on MatTek Corporation (Ashland, Massachusetts, United States) 35 mm coverslip dishes in F12 media (BioFluids, BioSource International, Carmarillo, California, United States) without phenol red and supplemented with 10 mM HEPES and antibiotics. Plasmid DNA at 0.5-2.0 ng/nl was injected in cell nuclei using a Narishige (Lake Forest, California, United States) IM-200 picoliter pressure injection system. OD microcapillary glass pipettes (1.0 mm) were pulled to a fine tip using a Narishige PB-7 needle puller. Cells were maintained at 37degreesC using a modified Harvard Apparatus (Hopkinton, Massachusetts, United States) microscope incubator mounted on a Nikon (Tokyo, Japan) Diaphot 300 inverted microscope. Images were collected using a Princeton Instruments MicroMax 1300Y cooled CCD camera (Roper Scientific, Tucson, Arizona, United States). Excitation and emission wavelengths were controlled using dichroic and bandbass filters from Omega Optical (Brattleboro, Vermont, United States) and a Sutter Instrument (Novato, California, United States) Lambda 10-2 filter wheel image acquisition. Device control and postacquisition processing were done with Isee Imaging Software (Inovision Corporation Raleigh, North Carolina, United States).
###end p 45
###begin title 46
Actinin dynamics display
###end title 46
###begin p 47
To display the changes in GFP-actinin distribution over time, images collected at 1 min intervals were used sequentially as red, green, and blue channels of a RGB composite image. Areas of signal that did not change have equal representation in each of the channels and generate a white signal in the final image. Areas of signal that did change on a minute-to-minute basis are indicated by either a red, green, or blue hue. For example, a region rich in red would indicate an signal present in the first image, but absent in the two sequential images, indicative of a withdraw or loss of signal in that region.
###end p 47
###begin title 48
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Generation of K228E mutant mice
###end title 48
###begin p 49
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 95 110 95 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 636 651 636 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 289 304 <span type="species:ncbi:10090">transgenic mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">Mice</span>
Previously, we described the development of a mouse model lacking detectable Actn4 expression (Kos et al. 2003). These mice harbor a germline mutation in exon 8 of Actn4 encoding a K228E substitution, as well as an intronic loxP-flanked neomycin resistance cassette. We bred these mice to transgenic mice with germline expression of Cre recombinase (129-TgN(Prm-Cre)58Og; Jackson Laboratory, Bar Harbor, Maine, United States). We verified excision of the neomycin resistance cassette by PCR. Heterozygous mice were crossed to obtain mice homozygous for the K228E substitution. Mice were genotyped for the K228E as described previously (Kos et al. 2003). We used Trizol reagent to extract RNA from kidneys for RT-PCR and for Northern blot analysis.
###end p 49
###begin title 50
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse phenotyping
###end title 50
###begin p 51
###xml 401 416 401 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 474 479 <span type="species:ncbi:10090">mouse</span>
###xml 652 657 <span type="species:ncbi:9606">Women</span>
Freshly harvested kidneys were fixed in Bouin's solution. H & E and PAS staining were performed using standard methodology. Electron microscopy was performed after fixation in Karnovsky's media using standard diagnostic protocols. For the electron micrographs, all of the glomeruli imaged were from as deep into the renal cortex as possible. Indirect IF studies were performed using standard methods (Kos et al. 2003). Urine microalbumin was assessed by a reader blinded to mouse genotype using albumin dipsticks (Albustix, Bayer, Leverkusen, Germany). BUN and creatinine measurements were performed at the clinical chemistry laboratory at Brigham and Women's Hospital.
###end p 51
###begin title 52
Supporting Information
###end title 52
###begin title 53
Podocytes Following Nuclear Injection of Wild-Type GFP-alpha-Actinin-4 cDNA
###end title 53
###begin p 54
(14.8 MB MOV).
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin title 56
Podocytes Following Nuclear Injection of K228E GFP-alpha-Actinin-4 cDNA
###end title 56
###begin p 57
(11.8 MB MOV).
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin title 59
Podocytes Following Nuclear Injection of T232I GFP-alpha-Actinin-4 cDNA
###end title 59
###begin p 60
(10.9 MB MOV).
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin title 62
Accession Numbers
###end title 62
###begin p 63
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 230 236 230 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSGS-1</italic>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
GenBank accession numbers for genes and proteins discussed in this paper are NM_004924 and NP_004915 (human ACTN4; also LocusLink ID 81) and NM_021895 and NP_068695 (mouse Actn4; also LocusLink ID 60595). OMIM numbers are 603278 (FSGS-1) and 604638 (ACTN4).
###end p 63
###begin p 64
These experiments were supported by National Institutes of Health grants DK59588 (to MRP), GM55223 (to BMD), and GM057256 (to PGA). We thank Larry Holzman and Peter Mundel for gifts of anti-synaptopodin and anti-nephrin antibodies and Dr. Mundel for the podocyte cell line. We thank Kazufumi Honda and Carol Otey for the GFP-alpha-actinin-4 clone.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
Huntingtin aggregation and toxicity in Huntington's disease
###end article-title 66
###begin article-title 67
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHS2</italic>
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome
###end article-title 67
###begin article-title 68
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
###end article-title 68
###begin article-title 69
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 109 116 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human skeletal muscle-specific alpha-actinin-2 and -3 isoforms form homodimers and heterodimers in vitro and in vivo
###end article-title 69
###begin article-title 70
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN
###end article-title 70
###begin article-title 71
A rapid purification of alpha-actinin, filamin, and a 130,000-dalton protein from smooth muscle
###end article-title 71
###begin article-title 72
Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion
###end article-title 72
###begin article-title 73
Protein aggregation in disease: A role for folding intermediates forming specific multimeric interactions
###end article-title 73
###begin article-title 74
Focal segmental glomerulosclerosis
###end article-title 74
###begin article-title 75
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTN4</italic>
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis
###end article-title 75
###begin article-title 76
Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome
###end article-title 76
###begin article-title 77
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in alpha-actinin-4 have severe glomerular disease
###end article-title 77
###begin article-title 78
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4
###end article-title 78
###begin article-title 79
Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes
###end article-title 79
###begin article-title 80
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Congenital nephrotic syndrome in mice lacking CD2-associated protein
###end article-title 80
###begin article-title 81
Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis
###end article-title 81
###begin article-title 82
Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome
###end article-title 82
###begin article-title 83
Getting a foothold in nephrotic syndrome
###end article-title 83
###begin article-title 84
Alpha-actinins. In: Creighton TE, editor. Encyclopedia of molecular medicine
###end article-title 84
###begin article-title 85
Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion
###end article-title 85
###begin title 86
Abbreviations
###end title 86
###begin p 87
blood urea nitrogen
###end p 87
###begin p 88
###xml 6 10 <span type="species:ncbi:9913">calf</span>
fetal calf serum
###end p 88
###begin p 89
focal segmental glomerulosclerosis
###end p 89
###begin p 90
green fluorescent protein
###end p 90
###begin p 91
hematoxylin and eosin
###end p 91
###begin p 92
immunofluorescence
###end p 92
###begin p 93
interferon
###end p 93
###begin p 94
periodic acid-Schiff
###end p 94
###begin p 95
phosphate-buffered saline
###end p 95
###begin title 96
Figures and Tables
###end title 96
###begin title 97
Mutant alpha-Actinin-4 Sediments Abnormally
###end title 97
###begin p 98
(A) Pattern of sedimentation of alpha-actinin-4 in a 10%-40% sucrose gradient. Results shown are for wild-type alpha-actinin-4, K228E alpha-actinin-4, and K228E alpha-actinin-4 after addition of excess cold (wild-type) alpha-actinin. A fraction of the mutant alpha-actinin-4 sedimented at least as quickly than the highest molecular weight marker, catalase, which has a sedimentation coefficient of 11.3. This was observed with all of the other mutants tested as well (data not shown), but never with labeled wild-type alpha-actinin-4. Addition of cold alpha-actinin did not alter the sedimentation pattern seen with the mutant form of alpha-actinin-4.
###end p 98
###begin p 99
(B) Results illustrated graphically. Units are arbitrary.
###end p 99
###begin title 100
Mutant alpha-Actinin-4 Behavior in Cells
###end title 100
###begin p 101
###xml 435 456 431 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4a1">Materials and Methods</xref>
###xml 958 974 950 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="sv001">See Videos S1&#8211;S3</xref>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
(A) Mutant and wild-type alpha-actinin-4 show different localization and dynamics when expressed in a conditionally immortalized differentiated mouse podocyte cell line. Differentiated podocytes were injected in the nucleus with equal concentrations of expression plasmid for GFP fusions of mutant and wild-type actinins. At 2-4 h after injections, cells were imaged and both phase and fluorescence images recorded as described in the Materials and Methods. To illustrate changes in distribution of the fluorescence signal, three fluorescence images each 1 min apart were overlaid as red, green, and blue panes. Areas of fluorescence that were the same in all panes show as white, while dynamic areas are indicated by the color. The top panel indicates the initial phase and overlain dynamic fluorescence images of wild-type alpha-actinin-4, while the bottom two panels illustrate characteristic results for mutants K228E and T232I at 3 min time intervals. (See Videos S1-S3.)
###end p 101
###begin p 102
###xml 65 69 <span type="species:ncbi:10090">mice</span>
(B) Transfections in podocytes derived from mutant and wild-type mice. When transfected into conditionally immortalized podocytes of all three alpha-actinin-4 genotypes (+/+, K228E/+, or K228E/K228E), wild-type GFP-alpha-actinin-4 shows diffuse cytoskeletal localization. Mutant GFP-alpha-actinin-4 shows a similar alteration in localization when expressed in these three cells types.
###end p 102
###begin title 103
###xml 10 15 <span type="species:ncbi:10090">Mouse</span>
"Knockin" Mouse Model
###end title 103
###begin p 104
###xml 57 72 57 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kos1">Kos et al. 2003</xref>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 259 262 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 263 278 <span type="species:ncbi:10090">transgenic mice</span>
(A) Targeting construct. As we have described elsewhere (Kos et al. 2003), targeting initially resulted in a "knockout" allele, due to disruption of normal transcription, presumably by the intronic loxP-flanked neomycin resistance cassette. After breeding to Cre transgenic mice, this neomycin cassette was excised, as illustrated.
###end p 104
###begin p 105
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
(B) Northern blot analysis using kidney total RNA illustrates that the expression of the Actn4 transcript in K228E/K228E is similar to the expression in wild-type mice.
###end p 105
###begin p 106
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
(C) RT-PCR and sequencing of the relevant portion of Actn4 exon 8 confirms that the transcript in mice homozygous for the targeted allele contains the desired point mutation (top, wild-type; bottom, targeted).
###end p 106
###begin p 107
###xml 108 112 <span type="species:ncbi:10090">mice</span>
(D) Western blot showing markedly decreased expression of alpha-actinin-4 protein in K228E/K228E homozygous mice and moderately decreased expression in heterozygotes. Shown are blots using protein from cultured fibroblasts. Results were similar using protein extracted from lung, brain, liver, and kidney (data not shown). beta-actin control is shown below.
###end p 107
###begin p 108
###xml 105 123 101 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020167-Kaplan1">Kaplan et al. 2000</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
(E) Western blot showing expression of alpha-actinin-4 in lymphocytes from a human K228E/+ heterozygote (Kaplan et al. 2000) and three wild-type controls (two related, one unrelated). beta-actin control is shown below.
###end p 108
###begin title 109
alpha-Actinin-4 Synthesis and Degradation
###end title 109
###begin p 110
(A and B) Synthesis of alpha-actinin-4 by wild-type and K228E/K228E fibroblasts. The rate of increase in the accumulation of mutant and wild-type alpha-actinin-4 is similar, as indicated by the superimposed shapes of the synthesis curves.
###end p 110
###begin p 111
(C and D) Pulse-chase experiments showing degradation of alpha-actinin-4 in K228E/K228E cells. Half-life of wild-type alpha-actinin-4 is greater than 30 h. Half-life of mutant alpha-actinin-4 is approximately 15 h.
###end p 111
###begin p 112
(E) Half-life of K228E mutant alpha-actinin-4 is restored to near-normal levels by the addition of lactacystin. Shown is labeled alpha-actinin-4 levels, expressed as a percentage of alpha-actinin-4 at time 0 and at 16 h and in the presence of 2.5 muM lactacystin in DMSO or in DMSO alone.
###end p 112
###begin title 113
In Vivo Phenotype
###end title 113
###begin p 114
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 55 66 55 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 94 105 94 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 421 432 421 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
Electron micrographs from Actn4 wild-type (A) and Actn4K228E/K228E mice (B-D). As shown, Actn4K228E/K228E mice were found to have abnormalities that were typically focal, with some areas of podocyte foot process effacement (B), as well as areas that appeared essentially normal (C). Bottom image ([D] using tannic acid counterstaining) illustrates electron-dense deposits observed in several podocyte cell bodies in Actn4K228E/K228E mice. No such deposits were observed in wild-type or heterozygous mice.
###end p 114
###begin title 115
###xml 38 42 <span type="species:ncbi:10090">Mice</span>
Biochemical Characteristics of Mutant Mice
###end title 115
###begin p 116
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 46 53 46 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/&#8211;</sup>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 91 102 91 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
(A) Average BUN and creatinine levels in Actn4K228E/- (n = 12), Actn4+/+ (n = 8), and Actn4K228E/K228E (n = 12) mice at the time of sacrifice. Differences were not statistically significant. Error bars show standard deviation.
###end p 116
###begin p 117
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8211;</sup>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 56 63 56 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/&#8211;</sup>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 84 95 84 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
(B) Summary of proteinuria in wild-type, Actn4+/-, Actn4K228E/-, Actn4-/-, and Actn4K228E/K228E mice, measured by albumin dipstick. Distribution of measurements are illustrated graphically for each genotype.
###end p 117
###begin title 118
In Situ Protein Localization
###end title 118
###begin p 119
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn</italic>
###xml 66 73 66 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/+</sup>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actn4</italic>
###xml 85 96 85 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K228E/K228E</sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
(A) IF studies of glomerular protein expression in Actn4+/+, Actn4K228E/+ , and Actn4K228E/K228E mice. As indicated, expression of alpha-actinin-4, ZO-1, and nephrin is shown, as is a merged image of alpha-actinin-4 and ZO-1 expression.
###end p 119
###begin p 120
###xml 55 60 <span type="species:ncbi:9606">human</span>
(B) Glomerular expression of alpha-actinin-4 in normal human kidney and in an individual heterozygous for a K228E mutation.
###end p 120
###begin p 121
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflicts of interest.</bold>
Conflicts of interest. The authors have declared that no conflicts of interest exist.
###end p 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. JY, PGA, BMD, and MRP conceived and designed the experiments. JY, TCL, CHK, JMH, and PGA performed the experiments. JY, JMH, PGA, BMD, and MRP analyzed the data. JH, PGA, and MRP contributed reagents/materials/analysis tools. JY and MRP wrote the paper.
###end p 122
###begin p 123
Academic Editor: Peter Mundel, Albert Einstein College of Medicine
###end p 123

